Clinical Trial Update: Interleukin-2 in Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of Interleukin-2 in metastatic kidney cancer has been terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Renal Cell Cancer Metastatic, Kidney Cancer Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2017-09-27